Q (QuackAI) fluctuated 42.0% in 24 hours: driven by abnormal trading volume surge and liquidity sweep
Bitget Pulse2026/04/15 13:03Volatility Overview
In the past 24 hours, Q price rebounded from a low of $0.0080298 to a high of $0.0114, currently at $0.0113722, with a price swing amplitude reaching 42.0%. Trading volume saw an abnormal triple increase, accompanied by strong buying influx.
Brief Analysis of the Cause of Abnormal Movements
• Trading volume surged 3.0 times, suspected that smart money swept the liquidity near recent lows ($0.008486), triggering stop-losses and driving the rebound.
• After breaking through the recent high, a single candle surged by 30%, but low liquidity amplified the volatility.
No official announcements or major on-chain whale transactions have been confirmed.
Market Views and Outlook
The mainstream sentiment in the community is cautious, calling for “high volatility and easy manipulation,” advising not to chase the rally, and to wait for a pullback to $0.008239–$0.008895 and confirmation of a reversal signal (such as a pin bar or engulfing pattern) before entering a long position; if $0.008062 is lost, the low may further test $0.0078. Analysts highlight that risk management should be prioritized, and if there is a confirmed follow-up in the short term trading, it may continue to probe above $0.0093.
Note: This analysis is automatically generated by AI based on publicly available data and on-chain monitoring, and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
